NCT02170792View on ClinicalTrials.gov

Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MS

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

March 31, 2001

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS

Low, medium or high dose

DRUG

Ranitidine

150mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02170792 - Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MS | Biotech Hunter | Biotech Hunter